Ambien vs Lunesta

How they're similar

Zolpidem and eszopiclone have a great deal in common. They belong to the same class, and most of what is true of one is true of the other.

• Both are z-drugs, also called nonbenzodiazepine hypnotics.
• Both act on the GABA-A receptor, binding selectively to the subtype tied to sedation, so the effect is more purely sleep-promoting.
• Both work fast, usually within about 30 minutes, which is why each is taken right before getting into bed.
• Both are Schedule IV controlled substances, a federal category for medications with accepted medical use and a recognized potential for misuse and dependence.
• Both carry the FDA boxed warning, the agency's strongest, about complex sleep behaviors such as sleepwalking, sleep-driving, and other activities done while not fully awake.
• Both carry a real but generally lower-than-benzodiazepine risk of dependence, tolerance, and rebound insomnia.
• Both can cause next-day impairment that can affect driving even when a person feels fine.
• Both are riskier in older adults and appear on the Beers list of medications to use with caution in that group.
• Both work best short-term, with cognitive behavioral therapy for insomnia, often shortened to CBT-I, the first-line treatment for chronic insomnia.
• Both are available as inexpensive generics, and the brand and generic versions contain the same active medication.

These shared cautions are real, and they are also manageable when treatment is planned and supervised. They are a reason for care, not for alarm.

How they differ

For two drugs in the same class, the differences are narrow. The main one is how long the effect lasts. The table below sums up the core points, with more detail underneath.

The central difference is duration. Both drugs start working within about 30 minutes, so neither has an edge on speed. What sets them apart is the other end of the curve. Zolpidem clears the body relatively quickly, with a half-life of roughly 2 to 3 hours. Eszopiclone lingers longer, with a half-life of roughly 6 hours.

That difference shapes what each drug is best at. Zolpidem immediate-release is aimed mainly at trouble falling asleep, and the extended-release form, Ambien CR, is meant to also help with staying asleep. Eszopiclone's longer action helps with both falling asleep and staying asleep through the night. The trade-off is next-morning grogginess. Because eszopiclone stays in the body longer, it is more likely to leave a person less alert the next day, and that effect can carry into driving.

There are a few practical differences too. Eszopiclone has a distinctive bitter or metallic aftertaste that can linger into the next day. It is harmless, but some people find it bothersome enough to switch. Zolpidem does not have that quirk. Zolpidem also comes in several forms: an immediate-release tablet, an extended-release tablet, sublingual tablets that dissolve under the tongue (including Intermezzo, a low dose for middle-of-the-night waking), and an oral spray. Eszopiclone comes only as tablets.

One more difference is dosing by sex. In 2013 the FDA lowered the recommended doses of zolpidem for women, because women clear the drug more slowly and were more likely to still have enough in the blood the next morning to impair driving. Eszopiclone dosing is not split by sex in that way. Eszopiclone is also one of the few hypnotics studied in trials lasting up to six months, though short-term use is still the usual approach for both drugs.

Side effects compared

The side effects of these two overlap closely, because they belong to the same class. Both can cause drowsiness, dizziness, dry mouth, headache, and next-day grogginess. With either drug, next-day grogginess is often a sign the dose is higher than that person needs, so it is worth raising with the prescriber.

The practical difference traces back to duration. Eszopiclone's longer action makes next-morning grogginess and next-day driving impairment more likely than with zolpidem. Eszopiclone also has the bitter or metallic aftertaste, which zolpidem does not. Both can cause dependence and tolerance with regular use, especially nightly use over long stretches, though the risk is generally lower than with benzodiazepines. Both can cause rebound insomnia when stopped after regular use, meaning a few nights of sleep that feel worse than before treatment. Older adults are more sensitive to both drugs and face a higher chance of falls, confusion, and next-day impairment.

Sleep, weight, and sexual effects

Both drugs are essentially weight-neutral. Neither tends to change appetite or body weight the way some psychiatric medications can. Sexual side effects are not a defining feature of either one, and neither causes the reduced sex drive or delayed orgasm linked to antidepressants. The one point worth noting on sexual effects is part of the boxed warning both drugs carry. Complex sleep behaviors have, rarely, included sexual activity while a person is not fully awake and with no memory of it afterward.

On sleep itself, the difference is the whole point of choosing between them. Zolpidem is built mainly to help a person fall asleep, and its short action means less drug in the body by morning. Eszopiclone's longer action helps hold sleep through the night, but the cost is a higher chance of feeling groggy the next day. With either drug, a lower dose and a full night of sleep, about 7 to 8 hours, both reduce next-day risk. Anything bothersome in any of these areas is worth raising with a prescriber.

Why a clinician might choose one over the other

Because the two are close, the choice often comes down to which part of the night is the problem.

A clinician might choose zolpidem when the main problem is falling asleep, when minimizing next-day grogginess matters, or when its flexible forms are useful. The sublingual and oral spray options, and the low-dose Intermezzo for middle-of-the-night waking, give zolpidem more ways to fit a particular sleep pattern. Its shorter action means less drug carried into the morning.

A clinician might choose eszopiclone when staying asleep through the night is the main problem. Its longer action covers more of the night, which can help someone who falls asleep fine but wakes in the early hours. The trade-off is accepting a bit more next-day grogginess and driving risk, plus the bitter aftertaste that some people dislike.

Prior response matters too. Someone who has done well on one of these drugs has a reasonable reason to stay with it. For either drug, the bigger question is often whether a nightly sleeping pill is the right tool at all, compared with CBT-I. Neither is a long-term solution for insomnia.

The bottom line

Zolpidem and eszopiclone are in the same class, with the same serious cautions, and the main difference is short-acting versus longer-acting. Zolpidem is aimed mainly at falling asleep and is less likely to leave next-day grogginess. Eszopiclone helps with both falling asleep and staying asleep, at the cost of more next-day risk and a bitter aftertaste. For ongoing insomnia, the real question is usually whether a nightly sleeping pill is the right tool at all, compared with CBT-I. That is a decision to make with a prescriber.

Common questions

Is Ambien or Lunesta stronger? Neither is simply stronger than the other. They differ in duration, not in raw power. Zolpidem is short-acting and aimed at falling asleep, while eszopiclone lasts longer and also helps with staying asleep. Doses are not interchangeable, and a prescriber matches the drug and dose to the situation.

Which one is better for staying asleep? Eszopiclone, in most cases. Its longer half-life, roughly 6 hours, helps hold sleep through the night, so it is often the better fit for someone who wakes in the early hours. The extended-release form of zolpidem, Ambien CR, is also designed to help with staying asleep, but standard zolpidem is aimed mainly at falling asleep.

Why does Lunesta leave a bad taste? A bitter or metallic aftertaste is a known quirk of eszopiclone, and it can linger into the next day. It is harmless, but some people find it bothersome enough to ask about a different option, including zolpidem, which does not have that effect.

Can I switch from one to the other? Yes, this is a recognized step, and a prescriber sometimes moves a person between these two drugs to better match which part of the night is the problem or to avoid a side effect like the aftertaste. The switch should be planned and supervised, since the two drugs are not dosed one for one.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

1. U.S. Food and Drug Administration. Zolpidem prescribing information.
2. U.S. Food and Drug Administration. Eszopiclone prescribing information.
3. MedlinePlus, U.S. National Library of Medicine.
4. National Institute of Mental Health. Mental health medications.